TAIPEI:(HRNW) Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the antiviral drug remdesivir after the United States bought nearly all global supplies.
Taiwan Centres for Disease Control Deputy Director-General Chuang Jen-hsiang told reporters on Tuesday that medical experts had decided to provisionally allow dexamethasone to be listed as a COVID-19 treatment but that procedures still needed to be completed before it could be given to any patients.
Taiwan has reported 476 cases of the new coronavirus, including seven deaths. Most of the cases are imported and almost all have recovered. It has kept numbers low thanks to early and effective prevention work.
Taiwan’s official Central News Agency said this week that stocks on the island of U.S. drugmaker Gilead’s COVID-19 medicine remdesivir were low.
Be the first to comment on "Taiwan provisionally approves dexamethasone as COVID-19 treatment"